Supernus Pharmaceuticals shares owned by AQR Capital Management
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by AQR Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $504k | 17k | 28.94 |
| 2023-09-30 | $367k | 13k | 27.57 |
| 2023-06-30 | $320k | 11k | 30.06 |
| 2023-03-31 | $382k | 11k | 36.23 |
| 2022-12-31 | $408k | 11k | 35.67 |
| 2022-09-30 | $278k | 8.2k | 33.84 |
| 2022-06-30 | $224k | 7.7k | 28.92 |
| 2021-09-30 | $237k | 8.9k | 26.67 |
| 2021-03-31 | $234k | 8.9k | 26.17 |
| 2020-12-31 | $1.2M | 48k | 25.16 |
| 2020-09-30 | $1.4M | 68k | 20.84 |
| 2020-06-30 | $2.0M | 84k | 23.75 |
| 2020-03-31 | $806k | 45k | 17.99 |
| 2019-09-30 | $411k | 15k | 27.49 |
| 2019-06-30 | $670k | 20k | 33.09 |
| 2019-03-31 | $533k | 15k | 35.01 |
| 2018-12-31 | $500k | 15k | 33.22 |
| 2018-09-30 | $5.0M | 84k | 59.85 |
| 2018-06-30 | $5.0M | 84k | 59.85 |
| 2018-03-31 | $6.1M | 133k | 45.80 |
| 2017-12-31 | $3.4M | 84k | 39.85 |
| 2017-09-30 | $3.5M | 88k | 40.00 |
| 2017-06-30 | $3.7M | 86k | 43.10 |
| 2017-03-31 | $2.8M | 90k | 31.30 |
| 2016-12-31 | $2.1M | 82k | 25.25 |
| 2016-09-30 | $2.6M | 105k | 24.73 |
| 2016-06-30 | $3.0M | 149k | 20.37 |
| 2016-03-31 | $2.6M | 172k | 15.25 |
| 2015-12-31 | $2.0M | 146k | 13.44 |
| 2015-09-30 | $3.0M | 212k | 14.03 |
| 2015-06-30 | $2.7M | 157k | 16.98 |
| 2015-03-31 | $1.6M | 134k | 12.10 |
| 2014-12-31 | $1.5M | 183k | 8.30 |
| 2014-09-30 | $666k | 77k | 8.69 |
| 2014-06-30 | $999k | 91k | 10.95 |
More positions owned by AQR Capital Management
Cigna Corp (CI)
View all positions for AQR Capital Management